Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Characterization of viro-immunological responses in a closely followed cohort of heavily pretreated patients: evidence from the GenPheRex Study.

HIV medicine - 1 Jul 2003

Torti C, Quiros-Roldan E, Scudeller L, Lo Caputo S, Tomasoni L, Castelli F, Poggio A, Delle Foglie P, Chirianni A, Sighinolfi L, Mazzotta F, Carosi G

Abstract excerpt

OBJECTIVES: To assess prevalence and predictive factors of viro-immunological discordant trends in a cohort of heavily pretreated patients. METHODS: Factors associated with viro-immunological discordant trends either as categorical or continuous measures have been studied in 159 heavily pretreated HIV-positive patients from a multicentre prospective study of real- vs. virtual-phenotype. Univariate and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to Antiretroviral Therapy, Highly Active

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to CD4 Lymphocyte Count

Share to HIV Protease Inhibitors

Share to Linear Models

Share to Logistic Models

Share to Salvage Therapy

Share to Viral Load

Source

Identifiers

PMID: 12859326
DOI: 10.1046/j.1468-1293.2003.00154.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Characterization of viro-immunological responses in a closely followed cohort of heavily pretreated patients: evidence from the GenPheRex Study.PMID 12859326Read ↗

Real versus virtual phenotype to guide treatment in heavily pretreated patients: 48-week follow-up of the Genotipo-Fenotipo di Resistenza (GenPheRex) trial.Semantic proximity Read ↗

Evaluating immunologic response and clinical deterioration in treatment-naive patients initiating first-line therapies infected with HIV-1 CRF01_AE and subtype B.Semantic proximity Read ↗

Genotypic resistance tests for the management of patients with viro-immunological discordant response to highly active antiretroviral therapy.Semantic proximity Read ↗

A randomized trial to investigate the recycling of stavudine and didanosine with and without hydroxyurea in salvage therapy (RESTART).Semantic proximity Read ↗

Salvage therapy: still more intuition than data.Semantic proximity Read ↗

Antiretroviral therapy suppressed participants with low CD4+ T-cell counts segregate according to opposite immunological phenotypes.Semantic proximity Read ↗

Longitudinal assessment of immune response and viral characteristics in HIV-infected patients with prolonged CD4(+)/viral load discordance.Semantic proximity Read ↗

Discordant response to HAART: reduction of viremia and replicative capacity of HIV strains in patients after genotype guided change of therapy.Semantic proximity Read ↗

Selection of antiretroviral therapy guided by genotypic or phenotypic resistance testing: an open-label, randomized, multicenter study (PhenGen).Semantic proximity Read ↗

Phenotype or virtual phenotype for choosing antiretroviral therapy after failure: a prospective, randomized study.Semantic proximity Read ↗

Phenotypic testing predicts virological response in successive protease inhibitor-based regimens.Semantic proximity Read ↗

Differences in disease progression in a cohort of long-term non-progressors after more than 16 years of HIV-1 infectionSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.